Canadian pharmaceutical company founded in 1988, producing generics, biosimilars, branded and hospital products from Boucherville, Quebec, with 380+ molecules and 400+ employees.
Groupe JAMP Pharma is a privately-owned Canadian pharmaceutical company founded in 1988 and headquartered in Boucherville, Quebec. It operates across generics, biosimilars, branded products, natural health products, cosmetics and hospital products, and ranks as the third-largest generic manufacturer in Quebec and the fifth in Canada. The JAMP Pharma division holds more than 380 molecules in its portfolio, and the group supplies over 11,500 pharmacies across the country.
Technical work spans generic pharmaceutical manufacturing, biosimilars and oncology products, contract manufacturing, quality assurance laboratory operations, cold chain storage and logistics, and controlled substance storage. JAMP Pharma Manufacturing began as a contract manufacturing organisation and now forms part of a vertically integrated operation covering commercial activities, warehousing, laboratory testing, vault storage and temperature-controlled distribution. Other divisions include BioJAMP (biosimilars), Orimed Pharma (branded products), Acute Care (hospital products), Wampole and Laboratoire Suisse (natural health products) and Cosmetic Import (beauty and personal care).
The group employs more than 400 people, with the team more than tripling over the past five years. It fields one of the largest sales forces in the Canadian generic industry. The company states a vision of becoming the largest Canadian-owned pharmaceutical company and cites five core values - Passion, Collaboration, Integrity, Accountability and Intrapreneurship - alongside commitments to quality, innovation and accessible healthcare for Canadians.
